Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Eagle Pharmaceuticals Inc...

    OTC: EGRX · Real-Time Price · USD
    1.25
    -0.25 (-16.67%)
    At close: Apr 04, 2025, 3:30 PM

    Eagle Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -2.67M 35.64M -8.63M
    Depreciation & Amortization
    		 16.67M 12.02M 3.76M
    Stock-Based Compensation
    		 n/a 16.45M 19.55M
    Other Working Capital
    		 n/a 19.8M 3.68M
    Other Non-Cash Items
    		 -14M 11.31M 7.61M
    Deferred Income Tax
    		 29.93M -8.32M -3.62M
    Change in Working Capital
    		 866K -16.4M 9.54M
    Operating Cash Flow
    		 30.8M 50.7M 28.22M
    Capital Expenditures
    		 n/a -178K -323K
    Cash Acquisitions
    		 n/a -74.15M n/a
    Purchase of Investments
    		 n/a -12.5M n/a
    Sales Maturities Of Investments
    		 n/a 74.15M n/a
    Other Investing Acitivies
    		 n/a -74.15M -5M
    Investing Cash Flow
    		 n/a -86.83M -5.32M
    Debt Repayment
    		 n/a 12.76M -8M
    Common Stock Repurchased
    		 n/a -18M -21.21M
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 n/a -969K 821K
    Financial Cash Flow
    		 n/a -6.21M -28.39M
    Net Cash Flow
    		 30.8M -42.34M -5.5M
    Free Cash Flow
    		 30.8M 50.52M 27.9M

    Add to Watchlist